TAILIN BIOTECH(SZ:300813) Zheng Quan Zhi Xing·2025-03-27 10:28Core Viewpoint - The legal opinion letter from Grandall Law Firm confirms that the procedures and results of the 2025 first extraordinary general meeting of shareholders of Zhejiang Tailin Biotechnology Co., Ltd. comply with relevant laws and regulations [4][12]. Group 1: Meeting Procedures - The fourth board of directors approved the proposal to convene the 2025 first extraordinary general meeting of shareholders [5]. - The meeting notification included details such as the time, location, convenor, voting methods, and agenda, ensuring shareholders could attend in person or via proxy [5][6]. - The meeting was held on March 27, 2025, with both on-site and online voting conducted [6][9]. Group 2: Attendance and Voting - A total of 117 shareholders attended the meeting, representing 68,066,519 shares, which is 55.6733% of the total voting shares [8]. - Online voting involved 112 shareholders, representing 590,921 shares, or 0.4876% of the total voting shares [7][8]. - The attendance of shareholders and their proxies was verified, confirming compliance with legal requirements [8][10]. Group 3: Resolutions and Voting Results - The meeting reviewed several resolutions, and the actual resolutions were consistent with the meeting notification [9][12]. - The voting results showed that 65,652,577 shares were in favor of the resolutions, with a small number of abstentions [10][12]. - The resolutions passed were deemed legal and valid according to the relevant laws and regulations [12].